AIDX
20/20 Biolabs, Inc.Company with tickers: AIDX
CIK
1139685
CUSIP
90138K101
Shares Outstanding
10,480,089
13F Activity (30d)
6 filings
6 filers
Price
$0.96
Market Cap
$10.27M
P/E Ratio
-1.26
EPS (Diluted)
$-0.76
52W High
$50.00
52W Low
$0.90
Price History
Institutional Holders
Short Volume
Short Interest
Fails to Deliver
Financials
SEC Filings
Earnings Calls
Insider Trades
Congressional Trades
| Line Item | Value | Unit | Period End | Form | Filed |
|---|---|---|---|---|---|
| Revenue | $353,375 | USD | 2026-03-31 | 10-Q | 2026-05-20 |
| Revenue (ASC 606) | — | ||||
| Cost of Revenue | $290,491 | USD | 2026-03-31 | 10-Q | 2026-05-20 |
| Gross Profit | $62,884 | USD | 2026-03-31 | 10-Q | 2026-05-20 |
| Operating Expenses | $1,506,240 | USD | 2026-03-31 | 10-Q | 2026-05-20 |
| Research & Development | $153,482 | USD | 2026-03-31 | 10-Q | 2026-05-20 |
| Operating Income | $-1,443,356 | USD | 2026-03-31 | 10-Q | 2026-05-20 |
| Net Income | $-2,174,836 | USD | 2026-03-31 | 10-Q | 2026-05-20 |
| EPS (Basic) | $-0.28 | USD/shares | 2026-03-31 | 10-Q | 2026-05-20 |
| EPS (Diluted) | $-0.28 | USD/shares | 2026-03-31 | 10-Q | 2026-05-20 |